Mitsubishi UFJ Asset Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Sell
25,162
-10,575
-30% -$94.8K ﹤0.01% 1005
2026
Q1
$291K Sell
35,737
-883
-2% -$8K ﹤0.01% 927
2025
Q4
$261K Buy
36,620
+5,820
+19% +$43.9K ﹤0.01% 975
2025
Q3
$267K Buy
30,800
+61
+0.2% +$475 ﹤0.01% 961
2025
Q2
$194K Sell
30,739
-2,430
-7% -$16.1K ﹤0.01% 980
2025
Q1
$213K Buy
33,169
+2,780
+9% +$23K ﹤0.01% 951
2024
Q4
$269K Buy
30,389
+12,744
+72% +$123K ﹤0.01% 941
2024
Q3
$223K Sell
17,645
-1,666
-9% -$21.5K ﹤0.01% 952
2024
Q2
$244K Sell
19,311
-21,917
-53% -$220K ﹤0.01% 939
2024
Q1
$197K Sell
41,228
-1,888
-4% -$8.76K ﹤0.01% 961
2023
Q4
$211K Buy
43,116
+2,583
+6% +$15.8K ﹤0.01% 1008
2023
Q3
$293K Buy
40,533
+4,045
+11% +$32.3K ﹤0.01% 988
2023
Q2
$271K Buy
36,488
+23,704
+185% +$186K ﹤0.01% 999
2023
Q1
$88.6K Hold
12,784
﹤0.01% 1096
2022
Q4
$125K Buy
12,784
+8,714
+214% +$154K ﹤0.01% 1069
2022
Q3
$74K Buy
4,070
+34
+0.8% +$1.47K ﹤0.01% 1113
2022
Q2
$208K Sell
4,036
-14,074
-78% -$729K ﹤0.01% 1041
2022
Q1
$1.33M Sell
18,110
-307
-2% -$27.4K 0.01% 799
2021
Q4
$2.63M Sell
18,417
-41
-0.2% -$7.04K 0.01% 699
2021
Q3
$3.83M Buy
18,458
+1,300
+8% +$287K 0.02% 612
2021
Q2
$3.64M Buy
+17,158
New +$3.14M 0.02% 627

Other funds holding NVAX

Mitsubishi UFJ Asset Management's NVAX Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management reduced its Novavax (NVAX) stake by 30% in Q2 2026, selling an estimated $94.8K and leaving 25,162 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

Mitsubishi UFJ Asset Management first reported a position in NVAX in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.83M in Q3 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 25,162 shares of Novavax worth $237K as of Q2 2026.
  • Mitsubishi UFJ Asset Management sold 10,575 Novavax shares in Q2 2026, an estimated $94.8K.
  • Novavax made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1005 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Novavax in Q2 2021 and has held it in 21 quarters since.
  • Mitsubishi UFJ Asset Management's Novavax position peaked at $3.83M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.